0000950170-24-073281.txt : 20240613 0000950170-24-073281.hdr.sgml : 20240613 20240613211836 ACCESSION NUMBER: 0000950170-24-073281 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240503 FILED AS OF DATE: 20240613 DATE AS OF CHANGE: 20240613 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Zovighian Bernard J CENTRAL INDEX KEY: 0001665141 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-15525 FILM NUMBER: 241042851 MAIL ADDRESS: STREET 1: C/O EDWARDS LIFESCIENCES CORPORATION STREET 2: ONE EDWARDS WAY CITY: IRVINE STATE: CA ZIP: 92614 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Edwards Lifesciences Corp CENTRAL INDEX KEY: 0001099800 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 364316614 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE EDWARDS WAY CITY: IRVINE STATE: CA ZIP: 92614 BUSINESS PHONE: 9492502500 MAIL ADDRESS: STREET 1: ONE EDWARDS WAY CITY: IRVINE STATE: CA ZIP: 92614 FORMER COMPANY: FORMER CONFORMED NAME: EDWARDS LIFESCIENCES CORP. DATE OF NAME CHANGE: 20090225 FORMER COMPANY: FORMER CONFORMED NAME: EDWARDS LIFESCIENCES CORP DATE OF NAME CHANGE: 20000203 FORMER COMPANY: FORMER CONFORMED NAME: CVG CONTROLLED INC DATE OF NAME CHANGE: 19991126 4/A 1 ownership.xml 4/A X0508 4/A 2024-05-03 2024-05-07 0001099800 Edwards Lifesciences Corp EW 0001665141 Zovighian Bernard J ONE EDWARDS WAY IRVINE CA 92614 true true false false CEO false Common Stock 3267.6552 I 401(k) Total reflects an acquisition of 580.2601 shares of the Issuer's Common Stock on May 6, 2024 under the Issuer's 401(k) Plan in a transaction exempted by Rule 16b-3, as well as 2,558 shares held under the Issuer's 401(k) Plan that were previously reported as directly held. This amendment to the Form 4 filed on May 7, 2024 by the Reporting Person is filed to remove the reporting of the acquisition of shares described in Footnote 1, as it was an exempt transaction in the Issuer's Common Stock pursuant to Section 16b-3(c) of the Securities Exchange Act of 1934, as amended, and to disclose the number of shares beneficially owned indirectly by the Reporting Person as represented on the most recent statement of the Issuer's 401(k) Plan Administrator. /s/ Linda J. Park, Attorney-in-Fact 2024-06-13